The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment

NCT07643896 · clinicaltrials.gov ↗

RECRUITING

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

Pregnant Individuals
Aneuploidy
Down Syndrome (Trisomy 21)
22q11.2 Deletion Syndrome
Trisomy 13
Trisomy 18
Sex Chromosome Abnormalities

Sponsor

BillionToOne Inc.